SNDX
Syndax Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$20.56
−0.58%Margins
Gross margin
97.5%
EBITDA margin
-53.7%
EBIT margin
-77.1%
Net margin
-87.6%
FCF margin
-87.6%
-1462.1%
Return on equity
-31.4%
Return on assets
-32.1%
Return on invested capital
0.43x
Asset turnover
-$220.6M
Cash from operations
$6.14
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026